Richard Ruzich and Andrew Alul will present at the American Conference Institute’s (ACI) Paragraph IV Disputes Conference on April 24-26 in New York City.
Ruzich will be a panelist for “On Sale Bar – Round II: Understanding The Impact of Helsinn on Pharmaceutical Patents in a Post – AIA Setting” on April 24. Alul will present “Illusory Safe Harbors: Exploring Uncertainties in the Boundaries of 271 (e) (1) and the Scope of Divided and Induced Infringement” on April 25.
The event is known as the pharmaceutical industry's leading forum on Hatch-Waxman litigation. To register or learn more about this event, please click here.